Position in DXCM
as of Mar 31, 2026
· filed Apr 7, 2026
Position Value
$229,659
+$16,745 QoQ
Shares Held
3,657
+14.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
10 quarters on record
Voting authority
Sole 9%
Shared 0%
None 91%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026U.S. Capital Wealth Advisors, LLC holds $6,192,060 across 7 Medical Devices names. DXCM ranks #7 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
23,658 | $2,428,966 | |
| 2 | BRKR |
Bruker Corp
|
35,475 | $1,281,357 | |
| 3 | MDT |
Medtronic plc
|
10,861 | $941,105 | |
| 4 | SYK |
Stryker Corp
|
2,283 | $750,170 | |
| 5 | BSX |
Boston Scientific Corp
|
5,033 | $315,820 | |
| 6 | PHG |
Koninklijke Philips NV
|
8,941 | $244,983 | |
| 7 | DXCM |
Dexcom Inc
This page
|
3,657 | $229,659 |
All Filings in DXCM
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $229,659 | 3,657 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $212,914 | 3,208 | Shares | Sole | 2026-01-23 | |
| 2023-06-30 | $1,899,377 | 14,780 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $1,717,140 | 14,780 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,673,347 | 14,777 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $1,186,193 | 14,728 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $1,097,677 | 14,728 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,885,246 | 3,685 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,245,524 | 4,182 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $3,718,101 | 6,799 | Shares | Sole | 2021-11-01 | |
| No filing history on record for this holder in this stock. | ||||||